Walvax沃森生物
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R&D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R&D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
CN
EN
Investors
Home
Investors
00
-0.22 (-0.6%)
Stock Code: 300142
Key Facts
5.3 billion
USD 5.3 billion market capitalization
706.4 million
USD 706.4 million revenue in 2022
152.7 million
USD 152.7 million operating profit in 2022
70.4%
70.4% increase in net profit attributable to Company owners in 2022
480.9 million
USD 480.9 million revenue in 2021
98.7 million
USD 98.7 million operating profit in 2021
Financial Reports
2023.08.28
2023 Interim Report
Download
2023.04.24
2023 First-Quarter Report
Download
2023.04.03
2022 Annual Report
Download
2022.08.11
2022 Interim Report
Download
2022.03.21
2021 Annual Report
Download
2021.03.21
2020 Annual Report
Download
2020.03.21
2019 Annual Report
Download